NCT03545243View on ClinicalTrials.gov

PPI and Microbiome in Healthy Volunteers and Functional Dyspepsia

PHASE4CompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

April 23, 2018

Primary Completion Date

March 8, 2020

Study Completion Date

September 22, 2020

Conditions
Dysbiosis
Interventions
DRUG

Pantoprazole 40mg

Peroral Pantoprazole 40mg once daily during 28 days

OTHER

PPI withdrawal

PPI withdrawal for 8 weeks

Trial Locations (1)

3000

UZ Leuven, Leuven

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT03545243 - PPI and Microbiome in Healthy Volunteers and Functional Dyspepsia | Biotech Hunter | Biotech Hunter